\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ patient\\ is\\ undergoing\\ work\\ up\\ through\\ rheumatology\\.\ \(0\)\
\-\ ct\\ demonstrates\\ dilatation\\ of\\ the\\ distal\\ esophagus\\ with\\ an\\ air\\ fluid\\ level\\ consistent\\ with\\ a\\ patulous\\ esophagus\\ seen\\ in\\ scleroderma\\.\\ \\ interstitium\\ demonstrates\\ peripheral\\ fibrosis\\ in\\ the\\ lower\\ lobes\\ with\\ some\\ peripheral\\ involvement\\ in\\ the\\ bilateral\\ upper\\ lobes\\.\ \(0\)\
\-\ scleroderma\ \(13\)\
\-\ scleroderma\ \(13\)\
\-\ connective\\ tissue\\ disease\ \(9\)\
\-\ idiopathic\\ pulmonary\\ fibrosis\ \(5\)\
\-\ witheld\ \(4\)\
\-\ the\\ combination\\ of\\ peripheral\\ fibrosis\\ with\\ a\\ basilar\\ predominance\\ and\\ the\\ coexistence\\ of\\ a\\ patulous\\ esophagus\\ is\\ pathognomonic\\ for\\ scleroderma\\.\\ \\ without\\ the\\ associated\\ gastrointestinal\\ disease\\,\\ the\\ differential\\ diagnosis\\ would\\ include\\ connective\\ tissue\\ disease\\ \\(e\\.g\\.\\ rheumatoid\\ arthritis\\,\\ systemic\\ lupus\\ erythromatosis\\,\\ mixed\\ connective\\ tissue\\ disease\\)\\ and\\ idiopathic\\ pulmonary\\ fibrosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ scleroderma\\:\\ 0\\.43572817112385553\ \(0\)\
\-\ fibrosis\\:\\ 0\\.32628093736194846\ \(0\)\
\-\ connective\\:\\ 0\\.303351190439029\ \(0\)\
\-\ patulous\\:\\ 0\\.28015235240015623\ \(0\)\
\-\ esophagus\\:\\ 0\\.24056070564767726\ \(0\)\
\-\ peripheral\\:\\ 0\\.20888424020016702\ \(0\)\
\-\ idiopathic\\:\\ 0\\.16472861494800511\ \(0\)\
\-\ disease\\:\\ 0\\.16349088389354322\ \(0\)\
\-\ lobes\\:\\ 0\\.1624818182527315\ \(0\)\
\-\ coexistence\\:\\ 0\\.15571679546342881\ \(0\)\
\-\ erythromatosis\\:\\ 0\\.15571679546342881\ \(0\)\
\-\ tissue\\:\\ 0\\.1532352744564627\ \(0\)\
\-\ the\\:\\ 0\\.13600274759626704\ \(0\)\
\-\ witheld\\:\\ 0\\.1343327653342753\ \(0\)\
\-\ rheumatology\\:\\ 0\\.12250109360882988\ \(0\)\
\-\ interstitium\\:\\ 0\\.12132342019440435\ \(0\)\
\-\ pulmonary\\:\\ 0\\.11870374563659788\ \(0\)\
\-\ predominance\\:\\ 0\\.10786485191485773\ \(0\)\
\-\ lupus\\:\\ 0\\.10146902428141884\ \(0\)\
\-\ demonstrates\\:\\ 0\\.09783586653899509\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.09603318018941231\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.09577649123010497\ \(0\)\
\-\ basilar\\:\\ 0\\.09212109340040724\ \(0\)\
\-\ combination\\:\\ 0\\.09036382364420313\ \(0\)\
\-\ undergoing\\:\\ 0\\.08843598795922473\ \(0\)\
\-\ systemic\\:\\ 0\\.08640708735518136\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.08582840501806811\ \(0\)\
\-\ mixed\\:\\ 0\\.08060072806847376\ \(0\)\
\-\ dilatation\\:\\ 0\\.07948600307495302\ \(0\)\
\-\ work\\:\\ 0\\.07938818335668302\ \(0\)\
\-\ arthritis\\:\\ 0\\.07919420974517802\ \(0\)\
\-\ with\\:\\ 0\\.0762655272946774\ \(0\)\
\-\ in\\:\\ 0\\.07266793954048263\ \(0\)\
\-\ involvement\\:\\ 0\\.07047467476205564\ \(0\)\
\-\ would\\:\\ 0\\.06892686480869174\ \(0\)\
\-\ air\\:\\ 0\\.06368914021157174\ \(0\)\
\-\ differential\\:\\ 0\\.06326670147448905\ \(0\)\
\-\ some\\:\\ 0\\.061264636101305774\ \(0\)\
\-\ level\\:\\ 0\\.0588174797937697\ \(0\)\
\-\ through\\:\\ 0\\.057962401488514205\ \(0\)\
\-\ include\\:\\ 0\\.057934623623761186\ \(0\)\
\-\ of\\:\\ 0\\.05716498940346114\ \(0\)\
\-\ distal\\:\\ 0\\.05657474136094284\ \(0\)\
\-\ fluid\\:\\ 0\\.056219642496111465\ \(0\)\
\-\ is\\:\\ 0\\.05333120357755758\ \(0\)\
\-\ consistent\\:\\ 0\\.0527965774096021\ \(0\)\
\-\ bilateral\\:\\ 0\\.052330556340943676\ \(0\)\
\-\ upper\\:\\ 0\\.05203334347891733\ \(0\)\
\-\ without\\:\\ 0\\.05135933342045261\ \(0\)\
\-\ associated\\:\\ 0\\.05132161076615248\ \(0\)\
\-\ diagnosis\\:\\ 0\\.05047623163030864\ \(0\)\
\-\ lower\\:\\ 0\\.04975648566953756\ \(0\)\
\-\ up\\:\\ 0\\.0481655693665667\ \(0\)\
\-\ seen\\:\\ 0\\.04584129256869634\ \(0\)\
\-\ and\\:\\ 0\\.04024088694869592\ \(0\)\
\-\ an\\:\\ 0\\.03723419260677207\ \(0\)\
\-\ ct\\:\\ 0\\.03706990361838844\ \(0\)\
\-\ patient\\:\\ 0\\.03166976977815882\ \(0\)\
\-\ for\\:\\ 0\\.029512283168014894\ \(0\)\
